Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Antifungal resistance and susceptibility

32 та иш

  1. Rhino-orbital-cerebral mucormycosis in acute myeloid leukemia patients: A case series from Sri Lanka

    Pradeep Siriwardena, U. M. Wariyapperuma, Pasindu Nanayakkara +4

    ПрепринтAntifungal resistance and susceptibilityResearch Square20240 иқтибос
    ABI

  2. SAFETY AND TOLERABILITY RESEARCH OF THE NEW DRUG CANPROFEM-AK FOR THE TREATMENT OF CANDIDAL VAGINAL INFECTIONS (PHASE 1)

    А.S. BALGIMBAYEVA, А.К. САДАНОВ, Diana Tleubekova +7

    МақолаReproductive tract infections researchМИКРОБИОЛОГИЯ ЖӘНЕ ВИРУСОЛОГИЯ20250 иқтибос
    ABI

  3. Case of successful treatment of inasive aspergillosis in a patient with AIDS

    Nilufar Bobojonova

    МақолаNail Diseases and TreatmentsПрофилактическая медицина и здоровье20250 иқтибос
    ABI

  4. Antifungal susceptibility profile of clinically relevant species of the genus <i>Sporothrix:</i> establishment of Epidemiological Cutoff Values (ECVs) according to CLSI broth microdilution methodology

    Amanda Ribeiro dos Santos, A Bonifaz, Amanda Bombassaro +31

    МақолаFungal Infections and StudiesbioRxiv (Cold Spring Harbor Laboratory)20250 иқтибос
    ABI

  5. A Review on <i>Aspergillosis</i> in Turkey: As a Main Fungal Disease in Poultry

    Ansam Naji Aboud Alhassani, Abdulrahman T. Ahmed, Gaurav Sanghvi +7

    Шарҳ мақолаAntifungal resistance and susceptibilityVeterinary Medicine and Science20250 иқтибос
    ABI

  6. АНТИМИКРОБНАЯ АКТИВНОСТЬ ЛИЗОЦИМА В ОТНОШЕНИИ БАКТЕРИЙ РОДА STAPHYLOCOCCUS И ГРИБОВ РОДА CANDIDA

    Эмма Владимировна Мурадова, Ганжинабону Ильхомзода Рауфова

    МақолаPediatric health and respiratory diseasesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  7. АНТИМИКРОБНАЯ АКТИВНОСТЬ ЛИЗОЦИМА В ОТНОШЕНИИ БАКТЕРИЙ РОДА STAPHYLOCOCCUS И ГРИБОВ РОДА CANDIDA

    Эмма Владимировна Мурадова, Ганжинабону Ильхомзода Рауфова

    МақолаPediatric health and respiratory diseasesZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI